Abstract
Endothelin-1 (ET-1) has been implicated in the pathophysiology of chronic kidney disease (CKD) and ET receptor blockade has shown renoprotective effects in animals. We examined the haemodynamic and renal effects of an ET receptor antagonist, TAK-044, in patients with CKD.
Original language | English |
---|---|
Pages (from-to) | 3228-34 |
Number of pages | 7 |
Journal | Nephrology dialysis transplantation |
Volume | 22 |
Issue number | 11 |
DOIs | |
Publication status | Published - 7 Jun 2007 |